Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device

Michelle C. Montpetit, Jamile L. Shammo, Jerome Loew, Stephanie Dunlap, Salpy V. Pamboukian, Alain Heroux

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

An acquired form of sideroblastic anemia has been described in association with several drugs, especially anti-microbial agents. A case of sideroblastic anemia is presented in a patient with a left ventricular assist device drive-line infection who was receiving linezolid, an antibiotic used for serious infections with gram-positive organisms. This patient's anemia resolved after discontinuation of the drug; he subsequently underwent an uncomplicated orthotopic heart transplant with no recurrence of anemia. As linezolid has been shown to have hematologic side effects, blood count monitoring is recommended in patients receiving this drug for long-term therapy.

Original languageEnglish (US)
Pages (from-to)1119-1122
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume23
Issue number9
DOIs
StatePublished - Sep 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint Dive into the research topics of 'Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device'. Together they form a unique fingerprint.

  • Cite this